Qube Research & Technologies LTD Valneva Se Call Options Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
11Shares Held
619KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.05 Million0.15% of portfolio
-
Wells Fargo & Company San Francisco, CA216KShares$1.25 Million0.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$144,6270.08% of portfolio
-
Abc Arbitrage Sa Paris, I019.2KShares$111,2300.01% of portfolio
-
Morgan Stanley New York, NY3.56KShares$20,5530.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $399M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...